Mechanisms, Risk Factors, and Management of Acquired Long QT Syndrome: A Comprehensive Review

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">Female sex</td></tr><tr><td align="left">Hypokalemia</td></tr><tr><td align="left">Bradycardia</td></tr><tr><td align="left">Recent conversion from atrial fibrillation</td></tr><tr><td align="left">Congestive heart failure</td></tr><tr><td align="left">Left ventricular hypertrophy</td></tr><tr><td align="left">High drug concentrations</td></tr><tr><td align="left">Rapid rate of intravenous infusion with a QT-prolonging drug</td></tr><tr><td align="left">Base-line QT prolongation</td></tr><tr><td align="left">Subclinical long QT syndrome</td></tr><tr><td align="left">Ion-channel polymorphisms</td></tr><tr><td align="left">Severe hypomagnesemia</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Risk factors for drug-induced torsade de pointes.

The Scientific World Journal

tab1

Table 1

Table 1: Mechanisms, Risk Factors, and Management of Acquired Long QT Syndrome: A Comprehensive Review 